Work

Getting a handle on KRAS inhibitor resistance with hapten-mediated anti-tumor immunity

Year: 2022

Type: article

Source: Cancer Cell

DOI: 10.1016/j.ccell.2022.08.018

Authors: William A. Freed-Pastor, Andrew J. Aguirre

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Merck, Mirati Therapeutics

OpenAlex ID: W4295757808

FWCI: 0.309

Cites: 11

Cited by: 4

Related to: 10